Acadia Pharmaceuticals buy UBS Group AG
Start price
08.08.24
/
50%
€14.56
Target price
08.08.25
€21.10
Performance (%)
43.94%
End price
09.08.25
€20.95
Summary
This prediction ended on 09.08.25 with a price of €20.95. With a performance of 43.94% the BUY prediction by UBS_Group_AG was a big success. UBS_Group_AG has a follow-up prediction for Acadia Pharmaceuticals where he still thinks Acadia Pharmaceuticals is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Acadia Pharmaceuticals | 4.679% | 4.679% | 37.650% |
| iShares Core DAX® | 3.002% | 4.755% | 23.700% |
| iShares Nasdaq 100 | 2.966% | 0.363% | 8.027% |
| iShares Nikkei 225® | 5.606% | 4.528% | 20.313% |
| iShares S&P 500 | 2.312% | 1.811% | 5.451% |
Comments by UBS_Group_AG for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at UBS Group AG from $25.00 to $23.00. They now have a "buy" rating on the stock.
Ratings data for ACAD provided by MarketBeat
In the thread Trading Acadia Pharmaceuticals
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Current prediction by UBS_Group_AG for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€21.15
08.08.25
08.08.25
€30.87
08.08.26
08.08.26
11.06%
07.01.26
07.01.26
Stopped prediction by UBS_Group_AG for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€23.07
06.01.26
06.01.26
€34.12
06.01.27
06.01.27
1.82%
07.01.26
07.01.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€20.96
09.09.25
09.09.25
€33.13
09.09.26
09.09.26
12.07%
07.01.26
07.01.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€21.80
17.10.23
17.10.23
€31.28
17.10.24
17.10.24
-36.33%
18.10.24
18.10.24